Status:
COMPLETED
Natural History Study for Achromatopsia
Lead Sponsor:
MeiraGTx UK II Ltd
Conditions:
Achromatopsia
Eligibility:
All Genders
3-100 years
Brief Summary
In preparation for human clinical trials we intend to undertake a detailed phenotypic study to help to identify patients who may be suitable for therapeutic intervention. In addition, with the recent ...
Eligibility Criteria
Inclusion
- Patients with molecularly proven Achromatopsia or a typical clinical Achromatopsia phenotype with genetic screening pending.
- Minimum subject age of 3 years.
- Able to give consent/parent or guardian able to give consent.
Exclusion
- Patients unable or unwilling to undertake consent or clinical testing.
- Patients unwilling to donate a blood sample in order to establish the genetic cause of their condition.
Key Trial Info
Start Date :
September 13 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 18 2023
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04124185
Start Date
September 13 2011
End Date
May 18 2023
Last Update
June 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moorfields Eye Hospital NHS Foundation Trust
London, United Kingdom